HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fries, D. Articles by Hörmann, C. Search for Related Content PubMed PubMed Citation Articles by Fries, D. Articles by Hörmann, C. Related Collections Mechanical Circulatory Assistance

Ann Thorac Surg 2003;76:1593-1597
© 2003 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Coagulation monitoring and management of anticoagulation during cardiac assist device support

^a department of Anesthesia and Intensive Care Medicine, University of Innsbruck, Innsbruck, Austria
^b department of Pediatrics, University of Innsbruck, Innsbruck, Austria
^c department of Cardiac Surgery, University of Innsbruck, Innsbruck, Austria

Accepted for publication June 4, 2003.

^* Address reprint requests to Dr Fries, Department of Anaesthesia and Intensive Care Medicine, University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria.
e-mail: dietmar.fries{at}uibk.ac.at

BACKGROUND: The incidence of clinically significant thromboembolic events due to the use of cardiac assist device systems remains high. Despite the considerable advances in cardiac assist device technology, the monitoring and management of the hypercoagulable coagulation status, resulting from foreign surfaces of the assist device system, altered rheologic conditions, and blood stasis in the recipient heart remain a challenge. Moreover septic complications and insufficient anticoagulation are responsible for thromboembolic events.

METHODS: In addition to standard coagulation analysis, functional coagulation tests were performed including the use of a thrombelastographic monitoring system (ROTEG) and a platelet function analyzer (PFA-100).

RESULTS: Severe biventricular ischemic heart failure developed in a 58-year-old man with acute myocardial infarction and he needed a biventricular assist device for a bridge to cardiac transplantation. Although the patient received acenocoumarol (Sintrom; Novartis Pharma, Vienna, Austria) and acetylsalicylic acid (Aspisol; Bayer AG, Leverkusen, Germany) as usual, ROTEG and the PFA-100 detected hypercoagulability while routine coagulation screening tests showed hypocoagulability. Moreover thrombus formation surrounding the canula of the left ventricular assist device was detected. Antithrombotic therapy with clopidogrel (Plavix) was initiated. Coagulation was closely monitored with modified thrombelastography and the PFA-100 to achieve sufficient but not overwhelming anticoagulation therapy. Three months after biventricular assist device implantation the patient underwent successful transplantation with no major blood loss.

CONCLUSIONS: Thrombelastography should be the standard form of monitoring in such patients to decrease the risk of thromboembolic events and prevent bleeding complications.

This article has been cited by other articles:

				S. R. Wilson, M. M. Givertz, G. C. Stewart, and G. H. Mudge Jr Ventricular assist devices the challenges of outpatient management. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1647 - 1659. [Abstract] [Full Text] [PDF]

				B. Steinlechner, M. Dworschak, B. Birkenberg, M. Duris, P. Zeidler, H. Fischer, L. Milosevic, G. Wieselthaler, E. Wolner, P. Quehenberger, et al. Platelet Dysfunction in Outpatients With Left Ventricular Assist Devices Ann. Thorac. Surg., January 1, 2009; 87(1): 131 - 137. [Abstract] [Full Text] [PDF]

				A. Joshi, D. Smith, M. Arora, and R. Poston Anticoagulant monitoring in ventricular assist device patients: a feasibility study Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1035 - 1038. [Abstract] [Full Text] [PDF]

				K. Seibel, P. Berdat, C. Boillat, B. Wagner, Z. Zachariou, and U. Kessler Hemostasis Management in Pediatric Mechanical Circulatory Support Ann. Thorac. Surg., April 1, 2008; 85(4): 1453 - 1456. [Abstract] [Full Text] [PDF]

				T. Niemi, S. Kukkonen, P. Hammainen, R. Suojaranta-Ylinen, and J. Sipponen Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assist Perfusion, March 1, 2008; 23(2): 107 - 110. [Abstract] [PDF]

				A. Joshi, L. S. Magder, Z. Kon, S. Kallam, M. Kwon, R. Sangrampurkar, R. Pierson, and R. Poston Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100{beta}) and international normalized ratio (INR) in patients with ventricular assisted devices Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 323 - 327. [Abstract] [Full Text] [PDF]

				G. H. Dunnington Jr, J. Sleasman, A. Alkhaldi, M. P. Pelletier, B. A. Reitz, and R. C. Robbins Successful Bridge to Transplant Using the Berlin Heart Left Ventricular Assist Device in a 3-Month-Old Infant Ann. Thorac. Surg., March 1, 2006; 81(3): 1116 - 1118. [Abstract] [Full Text] [PDF]

				H. Tsukui, J. J. Teuteberg, S. Murali, D. M. McNamara, J. R. Buchanan, S. Winowich, E. Stanford, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Biventricular Assist Device Utilization for Patients with Morbid Congestive Heart Failure: A Justifiable Strategy Circulation, August 30, 2005; 112(9_suppl): I-65 - I-72. [Abstract] [Full Text] [PDF]